64cu-25%-canf-comb
Asymptomatic Carotid Artery Stenosis
Washington University School of MedicineActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
8 Active assets in the Asymptomatic Carotid Artery Stenosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Plavix Asan Medical Center | Phase 4 | BB |
Lipitor Columbia University | Phase 4 | BB |
EPHEDRINE, ANHYDROUS University Hospital, Clermont-Ferrand | Phase 4 | BB |
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Asan Medical Center | Phase 4 | BB |
Acetylsalicylic Acid Asan Medical Center | Phase 4 | BB |
View all 27 →
Same molecule, other indications
64cu-25%-canf-comb is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →